Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Pale Blue Dot in connection with fund establishment
Mandate

Vinge has advised Pale Blue Dot in connection with fund establishment

June 24, 2020 Capital Markets and Public M&A

Vinge has advised Pale Blue Dot in connection with the structuring, fund raising and establishment of Pale Blue Dot’s first fund.

The fund conducted its first close in June 2020 in the amount of EUR 53 million. Pale Blue Dot is a Swedish venture capital fund focusing on early investments in European climate technology companies.

Vinge’s team primarily consisted of Rickard Vernet, Jesper Ottergren, Joel Wennerholm, Martin Svanberg, as well as Mattias Schömer (Tax) and Viveka Claesson (Regulatory Issues).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026